A detailed history of La Financiere De L'Echiquier transactions in Moderna, Inc. stock. As of the latest transaction made, La Financiere De L'Echiquier holds 2,250 shares of MRNA stock, worth $86,310. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,250
Previous 2,450 8.16%
Holding current value
$86,310
Previous $261,000 2.3%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$101.21 - $166.61 $20,242 - $33,322
-200 Reduced 8.16%
2,250 $267,000
Q1 2024

Apr 29, 2024

BUY
$85.37 - $115.44 $21,342 - $28,860
250 Added 11.36%
2,450 $261,000
Q4 2023

Jan 25, 2024

SELL
$69.51 - $104.43 $6.4 Million - $9.61 Million
-92,047 Reduced 97.67%
2,200 $218,000
Q3 2023

Nov 09, 2023

BUY
$96.41 - $126.61 $3.17 Million - $4.16 Million
32,895 Added 53.62%
94,247 $9.73 Million
Q2 2023

Aug 10, 2023

SELL
$118.5 - $160.53 $1.63 Million - $2.21 Million
-13,741 Reduced 18.3%
61,352 $7.45 Million
Q1 2023

May 03, 2023

BUY
$135.66 - $197.02 $3.99 Million - $5.8 Million
29,445 Added 64.5%
75,093 $11.5 Million
Q4 2022

Feb 09, 2023

SELL
$118.38 - $210.04 $338,211 - $600,084
-2,857 Reduced 5.89%
45,648 $8.2 Million
Q3 2022

Nov 02, 2022

SELL
$118.07 - $194.18 $327,290 - $538,266
-2,772 Reduced 5.41%
48,505 $5.74 Million
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $722,457 - $1.09 Million
-6,168 Reduced 10.74%
51,277 $7.33 Million
Q1 2022

May 05, 2022

BUY
$126.46 - $235.05 $2.01 Million - $3.73 Million
15,877 Added 38.2%
57,445 $9.9 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $8.48 Million - $13.8 Million
37,568 Added 939.2%
41,568 $10.6 Million
Q3 2021

Oct 29, 2021

BUY
$221.9 - $484.47 $887,600 - $1.94 Million
4,000 New
4,000 $1.54 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track La Financiere De L'Echiquier Portfolio

Follow La Financiere De L'Echiquier and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of La Financiere De L'Echiquier, based on Form 13F filings with the SEC.

News

Stay updated on La Financiere De L'Echiquier with notifications on news.